Ocuphire Appoints Rick Rodgers as Interim Chief Executive Officer

April 21, 2023

https://www.globenewswire.com/news-release/2023/04/21/2651886/0/en/Ocuphire-Appoints-Rick-Rodgers-as-Interim-Chief-Executive-Officer.html

FARMINGTON HILLS, Mich., April 21, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders, today announced that it has appointed Rick Rodgers as Interim Chief Executive Officer and President. Mr. Rodgers is succeeding Mina Sooch. Ocuphire has retained an executive search firm to assist in identifying a permanent CEO.

Read more at globenewswire.com

Related news for (OCUP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.